Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pirarubicin hydrochloride

Known as: (2"R)-4'-O-Tetrahydropyranyladriamycin Hydrochloride, 4'-O-Tetrahydropyranyl Doxorubicin HCl, THP-adriamycin Hydrochloride 
The hydrochloride salt form of pirarubicin, an analogue of the anthracycline antineoplastic antibiotic doxorubicin with antineoplastic activity… Expand
National Institutes of Health

Related topics

Related topics

1 relation
Pirarubicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Application of lobaplatin in trans-catheter arterial chemoembolization for primary hepatic carcinoma.
OBJECTIVE To explore the efficiency of single application of lobaplatin in tran-scatheter arterial chemoembolization (TACE) for… Expand
  • table 3
  • table 1
  • table 2
2008
2008
Styrene Maleic Acid-Pirarubicin Disrupts Tumor Microcirculation and Enhances the Permeability of Colorectal Liver Metastases
Background: Doxorubicin is a commonly used chemotherapy limited by cardiotoxicity. Pirarubicin, derived from doxorubicin… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2008
2008
Long-term follow-up of neoadjuvant intraarterial chemotherapy using an original four-lumen double-balloon (4L-DB) catheter for locally advanced uterine cervical cancer
BackgroundWe report the therapeutic potential, longterm survival, and toxicity of neoadjuvant intraarterial chemotherapy (NAIC… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
2005
2005
Diagnosing the Location of Carcinoma in situ (CIS) of the Urinary Bladder Using Pirarubicin Hydrochloride
Introduction: No established technique for locating solitary carcinoma in situ (CIS) of the urinary bladder or CIS accompanying… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
2004
2004
Pharmacokinetics and disposition of 4′-O-tetrahydropyranyladriamycin in mice by HPLC analysis
SummaryThe plasma level of 4′-O-tetrahydropyranyladriamycin (THP) declined rapidly after IV injection to mice, with a t1/2(α) of… Expand
  • figure 2
  • figure 3
Highly Cited
2000
Highly Cited
2000
Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma
The current study was conducted to evaluate retrospectively the effects of three kinds of regimens used in transcatheter arterial… Expand
1998
1998
Pancreatic cancer associated with granulocyte-colony stimulating factor production confirmed by immunohistochemistry.
We report an 83-year-old man with pancreatic body cancer of 4.5 cm in diameter. Peripheral leukocyte count was 15,700/microl and… Expand
1995
1995
Interaction of sphingomyelinase with sphingomyelin analogs modified at the C-1 and C-3 positions of the sphingosine backbone.
In this study, analogs differing at the C-1 or C-3 position of the sphingosine backbone of sphingomyelin were examined in neutral… Expand
1992
1992
Phase II trial of 4′‐O‐tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma
Background. 4′‐O‐tetrahydropyranyladriamycin (Pirarubicin, Meiji Seika (USA) Inc., New York, NY) may be less toxic than… Expand
1986
1986
[A randomized controlled study of (2'' R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast…
A comparative study of two combination chemotherapy regimens including (2'' R)-4'-O-Tetrahydropyranyladriamycin (THP) or… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE